Janney Montgomery Scott Upgrades Techne Corp. (TECH) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Bio-Techne Releases Third Quarter Fiscal 2016 Results
May 3, 2016 7:00 AM EDTMINNEAPOLIS, May 3, 2016 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2016.
Third Quarter FY2016 Highlights
Third quarter organic revenue increased by 8% (15% reported) to $131.0 million. Delivered record third quarter adjusted earnings of $37.6 million and adjusted earnings per share (EPS) of $1.01, an increase of 14% from the prior year, with foreign currency exchange headwinds impacting results by ($0.02) or 2%. Generated operating cash flow of $37.1 million, an increase of 20% over prior year. Continued the trend of double-digit revenue growth in China,... More